Benproperine
Template:Short description Template:Drugbox
Benproperine (INN) is a cough suppressant.[1] It has been marketed in multiple countries in Central America and Europe, as the phosphate or pamoate salts in either tablet, dragée, or syrup form. Trade names include Blascorid in Italy and Sweden, Pectipront and Tussafug in Germany, and Pirexyl in Scandinavia. The recommended dosage for adults is 25 to 50 mg two to four times daily, and for children 25 mg once or twice daily. Adverse effects include dry mouth, dizziness, fatigue, and heartburn.[2]
Synthesis
The base-catalyzed ether formation between 2-benzylphenol (1) and 1,2-dichloropropane (2) gives 1-benzyl-2-(2-chloropropoxy)benzene (3).[3][4][5][6] Displacement of the remaining halogen with piperidine completes the synthesis of benproperine (4).
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ DK96113 idem Rubenstein K, <templatestyles src="Citation/styles.css"/>Template:Citation/make linkScript error: No such module "Check for unknown parameters". (1962 to Pharmacia AS).
- ↑ Kurt Rubinstein, U.S. patent 3117059 (1964 to Aktieselskabet Pharmacia).
- ↑ Byoung Mog Kwon, et al. <templatestyles src="Citation/styles.css"/>Template:Citation/make linkScript error: No such module "Check for unknown parameters". (to Korea Research Institute of Bioscience and Biotechnology KRIBB).
- ↑ Chin. J. Org. Chem. 2011, Vol. 31, Issue (02): 212-215.
Script error: No such module "Check for unknown parameters".
Script error: No such module "Navbox".